HWM
INTS icon

Hohimer Wealth Management’s Intensity Therapeutics INTS Stock Holding History

Hohimer Wealth Management’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,791
Closed -$384K – 235
2023
Q4 		$384K Sell
1,791
-5,668
-76% -$597K 0.1% 164
2023
Q3 		$740K Buy
+7,459
New +$1.03M 0.21% 123

Other funds holding INTS

SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
BW
Bison Wealth Atlanta, Georgia $454M AUM 22.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hohimer Wealth Management's INTS Position: Q1 2024 in Review

Hohimer Wealth Management sold out of Intensity Therapeutics (INTS) in Q1 2024, closing a stake of 1,791 shares — an estimated $384K sold.

Hohimer Wealth Management first reported a position in INTS in Q3 2023 and held it in 2 quarters. The position peaked at $740K in Q3 2023. 17 funds tracked by Wall St. Rank hold INTS as of Q1 2024.

  • Hohimer Wealth Management reported no remaining Intensity Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Hohimer Wealth Management sold 1,791 Intensity Therapeutics shares in Q1 2024, an estimated $384K.
  • Hohimer Wealth Management first reported a position in Intensity Therapeutics in Q3 2023 and held it in 2 quarters.
  • Hohimer Wealth Management's Intensity Therapeutics position peaked at $740K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q1 2024.

Based on Hohimer Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.